Buy Flubrotizolam 0.5 mg Pellets – Premium Research Chemical | euro-labchems.com

Buy Flubrotizolam 0.5 mg Pellets (2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) CAS Number: 57801-95-3 Molecular Formula: C₁₅H₁₀BrFN₄S Molecular Weight: 377.24 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Exactly 0.5 mg Flubrotizolam Form: Compressed pharmaceutical-grade pellets (uniform, scored for precision) Quantity options: 10, 20, 50, 100, 200 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com supplies lab-tested Flubrotizolam 0.5 mg pellets – a potent thienotriazolodiazepine research chemical and fluoro analog of brotizolam. First identified in designer markets around 2021, Flubrotizolam is a high-affinity GABA-A receptor positive allosteric modulator (primarily α1, α2, α3 subunits), producing classical benzodiazepine-like sedative, anxiolytic, hypnotic, muscle-relaxant, and amnesic effects in preclinical models.

What is Flubrotizolam?

Flubrotizolam is a thieno-triazolo designer benzodiazepine structurally similar to brotizolam but with a fluorine instead of chlorine at the 2-position of the phenyl ring. It is significantly more potent than etizolam (4–5× in some reports) and supports advanced pharmacological, receptor-binding, metabolic, toxicological, and behavioral research on novel benzodiazepine ligands.

Key Product Specifications of Flubrotizolam 0.5 mg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & accurate dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 0.5 mg per pellet – microdose/standard research dose (analog potency: 0.25–1 mg common)

Research Effects & Characteristics

Duration: 8–14 hours Onset: 30–90 minutes Peak: 2–6 hours

Preclinical and analog literature indicate strong benzodiazepine effects: profound sedation, anxiolysis, muscle relaxation, anticonvulsant activity, amnesia, and hypnotic properties. Frequently described as more potent and longer-acting than etizolam with a smoother, less “blackout”-prone profile at research doses.

Possible side effects (dose-dependent, research observations): excessive sedation, respiratory depression risk, ataxia, cognitive impairment, rebound anxiety, tolerance/dependence potential, rare paradoxical agitation.

Flubrotizolam 0.5 mg pellets are sold strictly for scientific research – not for human/veterinary consumption. Verify local regulations. Full CoA available.

Premium Flubrotizolam pellets for precise benzodiazepine receptor research from euro-labchems.com – your trusted specialist.